A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma.
Weiping LiuLingyan PingYan XieYingli SunTingting DuYi NiuGalia CisternasFunan HuangJose Garcia-VargasBarrett H ChildsAruna MehraSusanne ReschkeXiaopei WangYuqin SongJun ZhuPublished in: Cancer chemotherapy and pharmacology (2022)
NCT03498430 (April 13, 2018).